Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Frequency of some demographic characteristics (based on sex) of patients participating in the study

From: Cost-effectiveness and budget impact analysis of lisdexamfetamine versus methylphenidate for patients under 18 with attention-deficit/hyperactivity disorder in Iran

Demographic characteristics

Male number (percentage)

Female number (percentage)

110 (55.83)

87 (44.16)

Age

Under 5 years

38 (34.54)

22 (25.28)

5–12 years

53 (48.18)

46 (52.87)

12–18 years

19 (17.27)

19 (21.83)

Place of residence of the patient in terms of urban/rural

Urban

85 (77.27)

59 (67.81)

Rural

25 (22.72)

28 (32.18)

Education

Not school aged

39 (35.45)

27 (31.03)

Primary

44 (40.0)

34 (39.08)

High school

27 (24.54)

26 (29.88)

Having insurance

Yes

89 (80.90)

69 (79.31)

No

21 (19.09)

18 (20.68)

Insurance type

No insurance

21 (19.09)

18 (20.68)

Iranian health insurance

53 (48.18)

43 (49.42)

Social security insurance

28 (25.45)

22 (25.28)

Armed forces insurance

8 (7.27)

4 (4.59)

Supplementary insurance

Yes

28 (25.45)

24 (27.58)

No

82 (74.54)

63 (72.41)